NYSE:DVADavita Stock Price, Forecast & News

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DVA shares have increased by 2.6% and is now trading at $76.81. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 9 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Davita.

Davita is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Davita.

Davita Inc (NYSE:DVA) released its earnings results on Tuesday, May, 5th. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.36. The company earned $2.84 billion during the quarter, compared to analyst estimates of $2.84 billion. Davita had a return on equity of 32.45% and a net margin of 7.85%. The company's quarterly revenue was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $0.91 EPS. View Davita's earnings history.

Davita updated its FY20 earnings guidance on Tuesday, May, 5th. The company provided earnings per share (EPS) guidance of $5.75-6.25 for the period, compared to the Thomson Reuters consensus estimate of $6.01. The company issued revenue guidance of $11.5-11.7 billion, compared to the consensus revenue estimate of $11.65 billion.

11 brokers have issued 12-month price targets for Davita's stock. Their forecasts range from $57.00 to $90.00. On average, they expect Davita's stock price to reach $68.86 in the next twelve months. This suggests that the stock has a possible downside of 10.4%. View analysts' price targets for Davita.

Press coverage about DVA stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Davita earned a daily sentiment score of 1.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutDavita.

Davita saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 5,500,000 shares, a decline of 5.2% from the April 30th total of 5,800,000 shares. Based on an average daily volume of 1,690,000 shares, the short-interest ratio is currently 3.3 days. Currently, 4.6% of the shares of the company are short sold. View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Gilead Sciences (GILD).

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (5.90%), State Street Corp (3.71%), Bank of New York Mellon Corp (2.26%), Geode Capital Management LLC (1.36%), Invesco Ltd. (1.24%) and Robeco Institutional Asset Management B.V. (1.14%). Company insiders that own Davita stock include John M Nehra, Kent J Thiry, Pamela M Arway and Paul J Diaz. View institutional ownership trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., State Street Corp, Wedge Capital Management L L P NC, Paloma Partners Management Co, WINTON GROUP Ltd, KBC Group NV, BlackRock Inc., and California Public Employees Retirement System. Company insiders that have sold Davita company stock in the last year include John M Nehra, Kent J Thiry, Pamela M Arway, and Paul J Diaz. View insider buying and selling activity for Davita.

DVA stock was purchased by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Bank of New York Mellon Corp, Janus Henderson Group PLC, PGGM Investments, Hexavest Inc., Pictet Asset Management Ltd., AJO LP, and Sumitomo Mitsui Trust Holdings Inc.. View insider buying and selling activity for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $76.81.

Davita has a market capitalization of $9.36 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

The official website for Davita is www.davita.com.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]